Methodological and statistical approaches to criteria development in rheumatic diseases-Reference-Cited by-同舟云学术

Methodological and statistical approaches to criteria development in rheumatic diseases

Published:1995-05 Issue:2 Volume:9 Page:253-266
ISSN:0950-3579
Container-title:Baillière's Clinical Rheumatology
language:en
Short-container-title:Baillière's Clinical Rheumatology

Author:

Felson David T.,Anderson Jennifer J.

Publisher

Elsevier BV

Subject

Rheumatology

Reference34 articles.

1. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand;Altman;Arthritis and Rheumatism,1990

2. Development of criteria for the classification and reporting of osteoarthritis.Classification of osteoarthritis of the knee;Altman;Arthritis and Rheumatism,1986

3. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip;Altman;Arthritis and Rheumatism,1991

4. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis;Amett;Arthritis and Rheumatism,1988

5. Neural networks as expert systems in rheumatic disease diagnosis: Artificial intelligence or intelligent artifice?;Aston;Journal of Rheumatology,1993

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial;Arthritis Research & Therapy;2024-07-29

2. Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study;RMD Open;2024-07

3. Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT);The Journal of Rheumatology;2024-04-15

4. Development of the Takayasu Arteritis Integrated Disease Activity Index;Arthritis Care & Research;2024-01-26

5. The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria;Arthritis & Rheumatology;2023-08-28